Home > Cashflow Statement > BALAXI PHARMACEUTICALS

BALAXI PHARMACEUTICALS
Cashflow Statement

BALAXI PHARMACEUTICALS is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for BALAXI PHARMACEUTICALS
Please provide your vote to see the results

BALAXI PHARMACEUTICALS Last 5 Year Cashflow Statement History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Profit Before Tax₹29 Cr₹2.02 Cr₹57 Cr₹55 Cr₹44 Cr
Adjustment ₹7.43 Cr₹-1.14 Cr₹8.03 Cr₹1.18 Cr₹-0.59 Cr
Changes In working Capital ₹-68 Cr₹11 Cr₹-47 Cr₹-16 Cr₹-41 Cr
Cash Flow after changes in Working Capital ₹-32 Cr₹12 Cr₹18 Cr₹40 Cr₹2.60 Cr
Cash Flow from Operating Activities ₹-35 Cr₹4.87 Cr₹6.08 Cr₹34 Cr₹0.00 Cr
Cash Flow from Investing Activities ₹-22 Cr₹-1.05 Cr₹-11 Cr₹-28 Cr₹-5.97 Cr
Cash Flow from Financing Activities ₹34 Cr₹30 Cr₹26 Cr₹-0.16 Cr₹3.65 Cr
Net Cash Inflow / Outflow ₹-23 Cr₹34 Cr₹21 Cr₹5.53 Cr₹-2.32 Cr
Opening Cash & Cash Equivalents ₹62 Cr₹28 Cr₹7.19 Cr₹1.66 Cr₹3.98 Cr
Cash & Cash Equivalent on Amalgamation / Take over / Merger -----
Cash & Cash Equivalent of Subsidiaries under liquidations -----
Translation adjustment on reserves / op cash balalces frgn subsidiaries -----
Effect of Foreign Exchange Fluctuations -----
Closing Cash & Cash Equivalent ₹39 Cr₹62 Cr₹28 Cr₹7.19 Cr₹1.66 Cr

Compare Cashflow Statement of peers of BALAXI PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BALAXI PHARMACEUTICALS ₹137.6 Cr -2% -13.2% -61.8% Stock Analytics
ADANI ENTERPRISES ₹278,793.0 Cr 0.2% -4% -0.1% Stock Analytics
REDINGTON ₹20,603.7 Cr -3.6% -2.9% 33.5% Stock Analytics
MMTC ₹10,333.5 Cr 9.1% 25.6% 7.3% Stock Analytics
HONASA CONSUMER ₹9,315.3 Cr -1.4% 9.5% 19.6% Stock Analytics
LLOYDS ENTERPRISES ₹8,921.2 Cr -5.8% -10% 21.9% Stock Analytics


BALAXI PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
BALAXI PHARMACEUTICALS

-2%

-13.2%

-61.8%

SENSEX

-0.7%

-1.9%

8%


You may also like the below Video Courses